HR 3276
116th Congress
House
Health
Health care costs and insurance
Health programs administration and funding
Inflation and prices
Medicaid
Prescription drugs
Retail and wholesale trades
Fair AMP Act
Introduced: June 13, 2019
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 14, 2019
Referred to the Subcommittee on Health.
Jun 13, 2019
Referred to the House Committee on Energy and Commerce.
Jun 13, 2019
Introduced in House
Plain-English summary
Fair and Accurate Medicaid Pricing Act of 2019 or the Fair AMP Act
This bill alters certain requirements and definitions under the Medicaid Drug Rebate Program relating to rebate calculations. Specifically, the bill repeals the requirement that drug manufacturers include the prices of certain authorized generic drugs when determining the average manufacturer price (AMP) of brand-name drugs (also known as a "blended AMP"), and excludes manufacturers from the definition of "wholesalers" for purposes of rebate calculations.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2
Cosponsors
1